Quantum-Si incorporated (QSI)
NASDAQ: QSI · Real-Time Price · USD
0.8451
-0.0162 (-1.88%)
At close: Mar 20, 2026, 4:00 PM EDT
0.8689
+0.0238 (2.82%)
After-hours: Mar 20, 2026, 7:48 PM EDT
Quantum-Si incorporated Employees
Quantum-Si incorporated had 145 employees as of December 31, 2025. The number of employees decreased by 4 or -2.68% compared to the previous year.
Employees
145
Change (1Y)
-4
Growth (1Y)
-2.68%
Revenue / Employee
$16,800
Profits / Employee
-$698,890
Market Cap
182.85M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 145 | -4 | -2.68% |
| Dec 31, 2024 | 149 | -10 | -6.29% |
| Dec 31, 2023 | 159 | -37 | -18.88% |
| Dec 31, 2022 | 196 | 43 | 28.10% |
| Dec 31, 2021 | 153 | 75 | 96.15% |
| Jun 30, 2021 | 112 | - | - |
| Mar 31, 2021 | 115 | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Inogen | 753 |
| InfuSystem Holdings | 473 |
| Quanterix | 450 |
| CVRx, Inc. | 223 |
| Sight Sciences | 186 |
| Electromed | 180 |
| 908 Devices | 172 |
| Nano-X Imaging | 165 |
QSI News
- 7 days ago - Quantum-Si Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
- 16 days ago - Quantum-Si incorporated (QSI) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 17 days ago - Quantum-Si Shares Slip After Q4 Revenue Miss - Benzinga
- 17 days ago - Quantum-Si Reports Fourth Quarter and Full Year 2025 Financial Results - Business Wire
- 5 weeks ago - Quantum-Si to Report Fourth Quarter and Full Year 2025 Financial Results on March 3, 2026 - Business Wire
- 6 weeks ago - Quantum-Si Announces the Release of Two New Manuscripts Demonstrating the Value of Single-Molecule Protein Sequencing in Clinical Proteomics and Pathogen & Toxin Detection - Business Wire
- 3 months ago - Quantum-Si Announces Launch of New Version 3 Library Preparation Kit and a Suite of Data Analysis Tool Enhancements - Business Wire
- 4 months ago - Quantum-Si Highlights Significant Development Advancements for Proteus™ and Industry Leading Technology Pipeline at Investor & Analyst Day - Business Wire